Race to Publish May Have Been GlaxoSmithKline's Downfall

Published: Aug 09, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Liu Xuebin recalls working 12-hour shifts and most weekends for months, under pressure to announce research results that would distinguish his GlaxoSmithKline Plc (GSK) lab in China as a force in multiple sclerosis research. It paid off -- for a while. Nature Medicine published findings about a potential new MS treatment approach in January 2010 and months later Liu was promoted to associate director of Glaxo’s global center for neuro-inflammation research in Shanghai. Two months ago, his career unraveled.

Help employers find you! Check out all the jobs and post your resume.

Back to news